DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Questcor Pharmaceuticals (NASDAQ: QCOR)

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

QCOR $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $47.71 - $97.80
Market Cap $0.00
P/E Ratio 16.36
Dividend (Yield) $1.20 (0.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 0
Average Daily Volume 0
Current FY EPS $7.19





Questcor Pharmaceuticals (QCOR) Description

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system. Website:

News & Commentary

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Greenberg on the Stock Market: Why Investigations No Longer Matter

Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick

10 best and worst S&P 500 stocks of 2014

Update: Questcor Shareholders Are The Net Gainers Of Acquisition Deal

Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index - Analyst Blog

Prem Watsa Buys 4 New Stocks

Retrophin CEO Under Fire for Twitter Faux Pas

Mallinckrodt Is Like Steak - Very Tasty

Paulson Bets Again On Mallinckrodt

Top Performing Funds Play Favorits

See More QCOR News...

QCOR's Top Competitors

QCOR $0.00 (0.00%)
Current stock: QCOR
JNJ $102.63 (1.39%)
Current stock: JNJ
NVS $89.24 (1.18%)
Current stock: NVS
RHHBY $36.65 (0.81%)
Current stock: RHHBY